[1]吕勇.中医药在腹膜透析治疗中的临床应用概论[J].现代中医药,2022,1(01):022-27.[doi:10.13424/j.cnki.mtcm.2022.01.004]
 LYU Yong.Introduction to Clinical Application of Traditional Chinese Medicine in Peritoneal Dialysis[J].Modern Traditional Chinese Medicine,2022,1(01):022-27.[doi:10.13424/j.cnki.mtcm.2022.01.004]
点击复制

中医药在腹膜透析治疗中的临床应用概论
分享到:

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
1
期数:
2022年01期
页码:
022-27
栏目:
指南与共识
出版日期:
2022-01-20

文章信息/Info

Title:
Introduction to Clinical Application of Traditional Chinese Medicine in Peritoneal Dialysis
文章编号:
1672-0571(2022)01-0022-06
作者:
吕勇
安徽中医药大学第一附属医院,安徽 合肥 230031
Author(s):
LYU Yong
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei 230031, China
关键词:
关键词:腹膜透析中医药辨证论治临床应用概论
Keywords:
Key words:Peritoneal dialysis Syndrome differentiation treatment of traditional Chinese medicine Clinical application Introduction
分类号:
R22
DOI:
10.13424/j.cnki.mtcm.2022.01.004
文献标志码:
A
摘要:
摘 要:腹膜透析是治疗终末期肾病的重要替代方法,我国腹膜透析患者人数庞大,且呈进行性增加趋势。在治疗过程中,许多致病因素影响腹膜透析患者的生存质量和生存周期,西医以对症治疗为主,疗效有限。中医药从终末期肾病腹膜透析患者本虚标实的基本病机出发,采用祛邪扶正的治疗原则为指导综合辨治,达培扶正气以提高患者生活质量和祛除病邪以延长患者生存周期的治疗目标。从保护残余肾功能、改善胃肠功能紊乱和营养状况、提高腹膜透析效能、防治腹膜透析相关感染和心血管并发症、改善腹膜纤维化和防治腹膜透析其他相关并发症等方面,概论中医药在腹膜透析治疗中的临床应用,以推进中医药在腹膜透析治疗领域中的应用。
Abstract:
Abstract:Peritoneal dialysis is an important alternative method for the treatment of end-stage renal disease. The number of peritoneal dialysis patients in China is huge and increasing gradually. In the treatment process, many pathogenic factors affect the quality of life and life cycle of peritoneal dialysis patients. Western medicine focuses on symptomatic treatment, and the curative effect is limited. Starting from the basic pathogenesis of deficiency and excess in peritoneal dialysis patients with end-stage renal disease, traditional Chinese medicine adopts the treatment principle of dispelling evil and strengthening health as the guidance, comprehensively syndrome differentiation and treatment, and reaches the treatment goal of cultivating healthy Qi to improve the quality of life of patients and dispelling disease evil to prolong the life cycle of patients. To protect residual renal function, improve gastrointestinal dysfunction and nutritional status, improve peritoneal dialysis efficiency, prevent peritoneal dialysis related infection and cardiovascular complications, improve peritoneal fibrosis and prevent other peritoneal dialysis related complications, introduce the clinical application of traditional Chinese medicine in peritoneal dialysis treatment, so as to promote the application of traditional Chinese medicine in the field of peritoneal dialysis treatment.

参考文献/References:

[1]陈香美,全国透析数据登记报告[R].2019.
[2]倪兆慧,金海姣.中国腹膜透析发展70年[J].中国血液净化,2019,18(10):661-663.
[3]Harvinder GS,Swee W C,Karupaiah T,et al.Dialysis Malnutrition and Malnutrition Inflammation Scores:screening tools for prediction of dialysis-related protein-energy wasting in Malaysia[J].Asia Pacific Journal of Clinical Nutrition,2016,25(1):26-33.
[4]Krishnamoorthy V,Sunder S,Mahapatra H S,et al.Evaluation of Protein-Energy Wasting and Inflammation on Patients Undergoing Continuous Ambulatory Peritoneal Dialysis and its Correlations[J].Nephro-Urology Monthly,2015,7(6):e33143.
[5]George,Kosmadakis,Julie,et al.Gastrointestinal Disorders in Peritoneal Dialysis Patients[J].American journal of nephrology,2018,48(5):319-325.
[6]王琳娜,刘志启,赵军,等.持续性非卧床腹膜透析患者死亡原因分析[J].齐齐哈尔医学院学报,2010,31 (24) :3894-3895.
[7]方吕贵,任翼,郭传,等.腹膜透析患者中医证型研究的文献特征分析[J].中国中医药图书情报杂志,2020,44(4):1-4.
[8]赵奎.CAPD患者的中医证候调查及其预后影响因素的相关性分析[D].合肥:安徽中医药大学,2018.
[9]Coronel F,Perez Flores I.Factors related to loss of residual renal function in peritoneal dialysis[J].Nefrologia,2008,28(6):39-44.
[10]Shemin D,Rostom AG,Laliberty P,et al.Residual renal function and mortality risk in hemodialysis patients[J].American Journal of Kidney Diseases,2001,38(1):85-90.
[11]胡岚,王亿平,金华,等.中医药保护腹膜透析患者残肾功能的Meta 分析[J].中医药临床杂志,2018,30(3):466-470.
[12]徐晶,张玲,盛梅笑.保肾片对腹膜透析患者残肾功能的保护作用[J].南京中医药大学学报:自然科学版,2012,28(1):23-26.
[13]李交,邓跃毅.健脾益肾活血方干预维持性腹膜透析患者的临床观察[J].中国中西医结合肾病杂志,2018,19(10):889-891.
[14]罗健华,邓跃毅,钟逸斐,等.补肾健脾方保护腹膜透析患者残余肾功能的前瞻性随机对照研究[J].临床肾脏病杂志,2015,15(8):461-464.
[15]张建,吕勇.参苓白术散加味对持续性不卧床腹膜透析患者营养不良的影响[J].中医药临床杂志,2018,30(12):2278-2282.
[16]冼启经.健脾益气法干预维持性腹膜透析相关营养不良的临床观察[J].云南中医中药杂志,2013,34(9):29-30.
[17]雷洋洋,杨波,裴明,等.扶肾颗粒联合灌肠治疗腹膜透析患者胃肠功能障碍46例[J].中国中西医结合外科杂志,2018,24(4):441-446.
[18]王文哲,毛辉辉,陈文莉.健脾益肾方加减治疗腹膜透析患者胃肠功能紊乱的疗效观察[J].时珍国医国药, 2017,28(5):1144-1145.
[19]吕勇,余蓉,刘玲,等.虫草制剂治疗持续性不卧床腹膜透析患者34例临床观察[J].新中医,2012,44(8):49-51.
[20]王东,王亿平,魏玲,等.健脾化湿方联合复方α- 酮酸对腹膜透析患者微炎症状态及腹膜功能的影响[J].中国中医基础医学杂志,2020,26(8):1091-1094.
[21]Szeto CC,Wong TY,Chow KM,et al.Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death.Nephrology Dialysis Transplantation,2003,18(5):977-982.
[22]姜涛,杨洪涛.杨洪涛教授运用中医药在腹膜透析治疗中的经验[J].中国中西医结合肾病杂志,2014,15(4):287-289.
[23]张苗,孙琤,蒋春明,等.黄芪注射液对腹膜透析病人腹腔巨噬细胞的影响[J].南京中医药大学学报,2007,23(5):319-321.
[24]吴国庆,薛松,范伟,等.益肾化瘀解毒方对连续不卧床腹膜透析腹膜炎患者血清HMGB-I和hs-CRP水平的影响[J].中医杂志,2015,56(2):124-127.
[25]吕勇,金华,王亿平,等.芙蓉膏外敷治疗腹膜透析导管出口处感染32例[J].安徽中医学院学报,2012,31(4):28-30.
[26]王洪霞,赵卫兵,李海玉,等.中药在腹膜透析置管术围手术期中的应用[J].中国中医基础医学杂志,2013,19(6):679-680.
[27]范汝艳,翁宁,徐佳美,等.持续性非卧床腹膜透析患者退出原因分析[J].中国中西医结合肾病杂志,2008,9(8):708-709.
[28]孟立锋,史伟.从痰瘀互结论腹膜纤维化的病因病机[J].新中医,2012,44(8):200-201.
[29]孟立锋,谢永祥,陶志虎,等.健脾化痰祛瘀方防治腹透患者腹膜纤维化60 例临床研究[J].中医临床研究,2015,7(30):70-73.
[30]曹曼,吕勇,张磊,等.基于“脾主腹”理论观察加味参苓白术散对腹膜透析患者腹膜功能及纤维化指标的影响[J].安徽中医药大学学报,2021,40(3):17-21.
[31]杨洪涛,鲁盈,邓跃毅,等.扶肾颗粒辨证干预腹膜透析患者的多中心临床研究[J].中国中西医结合肾病杂志,2012,13(5):410-412.
[32]吕勇,宋蓓蓓,金华.基于“治痿独取阳明”理论的中医综合疗法治疗腹膜透析并发不安腿综合征临床观察 [J].安徽中医药大学学报,2019,38(5):9-14.
[33]赵妍莉,王圣治,梁亮.加味芍药甘草汤治疗透析患者不宁腿综合征的临床观察[J].云南中医中药杂志,2019,40(2):43-45.
[34]Ko MJ,Wu HY,Chen HY,et al.Uremic pruritus,dialysis adequacy,and metabolic profiles in hemodialysis patients:a prospective 5 year cohort study[J].PLoS One,2013,8(8):e71404.
[35]Pisoni RL,Wikstrm B,Elder SJ,et al.Pruritus in haemodialysis patients:International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).Nephrology Dialysis Trans- plantation,2006,21(12):3495-3505.
[36]李雯.解毒止痒外洗方缓解腹膜透析患者瘙痒的临床疗效观察[D].广州:广州中医药大学,2020.
[37]李雯,卢富华,吴一帆.腹膜透析尿毒症瘙痒患者皮肤瘙痒程度与中医证候的相关性研究[J].中国中西医结合肾病杂志,2020,21(9):818-821.
[38]罗瑜.腹膜透析患者焦虑抑郁状况及与生活质量相关性调查分析[J].包头医学院学报,2016,32(5):9-11.
[39]章海芬,黄佳颖,顾爱萍,等.老年终末期肾病腹膜透析病人身体功能与抑郁症状关系的横断面研究[J].实用老年医学,2021,35(5):455-458.
[40]龚飞.四七汤合逍遥散治疗腹膜透析合并阈下抑郁(肝郁脾虚证)的临床研究[D].太原:山西中医药大学,2021.

相似文献/References:

[1]晏显妮1,刘小斌2,陈瑞芳2,等.中医药辨治肯尼迪病 2例[J].现代中医药,2019,(05):001.[doi:10.13424/j.cnki.mtcm.2019.05.001]
 Yan Xianni Liu Xiaobin Chen Ruifang Zhang Gao.Two Cases of Differentiation and Treatment of Kennedy’ s Disease with Traditional Chinese Medicine[J].Modern Traditional Chinese Medicine,2019,(01):001.[doi:10.13424/j.cnki.mtcm.2019.05.001]
[2]蔡传运.安神汤治疗老年性冠状动脉粥样硬化性心脏病合并失眠 30例疗效观察[J].现代中医药,2019,(05):054.[doi:10.13424/j.cnki.mtcm.2019.05.017]
[3]张静蓉1  陈四文2.儿童抽动障碍的中医药研究进展[J].现代中医药,2019,(04):137.[doi:10.13424/j.cnki.mtcm.2019.04.040]
[4]屈小会 张淑林* 张鲜芳 刘雪丽 李佩.谈中医药治疗高催乳素血症[J].现代中医药,2018,(04):084.[doi:10.13424/j.cnki.mtcm.2018.04.028]
[5]宗晓明.银玄泻心汤治疗氟尿嘧啶所致腹泻 59例[J].现代中医药,2018,(05):028.[doi:10.13424/j.cnki.mtcm.2018.05.009]
[6]刘宗玮 张德宏 * 毕华焱 王兴盛.退行性腰椎管狭窄症的中医药防治[J].现代中医药,2018,(05):099.[doi:10.13424/j.cnki.mtcm.2018.05.033]
[7]屈小会 赵虹 李佩 徐炜炜 刘雪丽.活血化瘀法治疗高催乳素血症探析[J].现代中医药,2018,(06):044.[doi:10.13424/j.cnki.mtcm.2018.06.016]
[8]余 牧 宋 健**.夏季胃病的中医药调治方法[J].现代中医药,2017,(05):073.[doi:10.13424/j.cnki.mtcm.2017.05.028]
 Yu Mu,Song Jian.On Regulation and Treatment of Summer Stomach Diseases by Chinese Medicine[J].Modern Traditional Chinese Medicine,2017,(01):073.[doi:10.13424/j.cnki.mtcm.2017.05.028]
[9]许金波 韩 辉** 吕丹丽.中医药防治合并认知障碍的 Wilson 病研究进展[J].现代中医药,2017,(06):138.[doi:10.13424/j.cnki.mtcm.2017.06.048]
[10]余勃1 许鹏2.加味乌头汤防治奥沙利铂所致周围神经毒性临床研究[J].现代中医药,2019,(02):063.[doi:10.13424/j.cnki.mtcm.2019.02.020]

备注/Memo

备注/Memo:
基金项目:第四批全国中医临床优秀人才研修项目资助(国中医药办人教发〔2017〕124号);安徽中医药大学第一附属医院临床科学研究项目(2020yfyzc13)
更新日期/Last Update: 2022-02-18